We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)
Product News

Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)

Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)
Product News

Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Quansys Biosciences Releases Q-Plex™ Pneumococcal Array (14-plex)"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Quansys Biosciences is releasing a new 14‐plex Pneumococcal Array. Quansys, an ISO 9001 and 13485 registered company, is providing this product for the evaluation and detection of IgG antibody concentrations to 14 pneumococcal polysaccharide (PnPs) serotypes (1, 3, 4, 6B, 7F, 8, 9N, 9V, 12F, 14, a8C, 19A, 19F and 23F).

With 14 unique serotypes represented by individual spots in the bottom of a 96 well plate, along with both CPS positive and negative controls, users can in as little as 90 minutes have over 1120 unique data points to analyze. For over 10 years, Quansys continues to provide novel, cost effective solutions.

“As we focus on current health concerns and risks, S. pneumoniae continues to create significant pain and suffering in the lives of millions of people. We are proud to be offering a high quality and cost effective solution for the assessment of the seraprevalance of this disease. We are excited to be launching this product on July 28th 2014 at this year’s annual meeting of the American Association of Clinical Chemistry,” said Matthew Groll, General Manager at Quansys Biosciences.

Advertisement